Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib
Drug Metabolism and Disposition · 2025
DOI: 10.1016/j.dmd.2025.100113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Aki T Heikkinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Certara Predictive Technologies, Sheffield, United Kingdom. Hauptthemen laut MEDLINE: Erlotinib Hydrochloride, Aldehyde Oxidase, Models, Biological. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Certara Predictive Technologies, Sheffield, United Kingdom.
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut.
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut. Electronic address: lloydweitat.tang@pfizer.com.
Förderung
- Pfizer
Zitieren
APA
Heikkinen, A. T., De Sousa Mendes, M., West, M. A., Yee, S. W., Gardner, I., & Tang, L. W. T. (2025). Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100113
Vancouver
Heikkinen AT, De Sousa Mendes M, West MA, Yee SW, Gardner I, Tang LWT. Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100113
BibTeX
@article{Heikkinen2025,
author = {Heikkinen, Aki T and De Sousa Mendes, Mailys and West, Mark A and Yee, Sook Wah and Gardner, Iain and Tang, Lloyd Wei Tat},
title = {Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1016/j.dmd.2025.100113}
}
EUVIMED